Cronos Group Inc. (CRON) stock: key figures, P/E, revenue and dividend

Health Care · Canada · ISIN CA22717L1013

Price
3.36 USD
Market cap
1.24 bn USD
P/E (2026)
–
P/S (2026)
–
Dividend yield
0.00 %
Net margin
–
Return on equity (ROE)
–
Return on assets (ROA)
–

Cronos Group Inc. financials

Fiscal year2025
Revenue146.59 m USD
Gross profit62.76 m USD
Operating income-17.40 m USD
EBIT-17.12 m USD
Net income-9.45 m USD
Diluted EPS – continuing operations-0.02 USD

Full history since 2012, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Cronos Group Inc.

Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures under the Spinach, Lord Jones, Lit, and Peace Naturals brand names. The company is headquartered in Stayner, Canada.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.